Cited by 1,690Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancerChromatin Remodeling and Cancer

The DOI matches its Crossref record; 115 of the 122 references it cites were found in a registry or an index.

The RB and p53 pathways in cancer

Open access

Sherr, Charles J, McCormick, Frank·2002·Cancer Cell

Open this paper in CoChat — free account Open PDF

Abstract

The life history of cancer cells encompasses a series of genetic missteps in which normal cells are progressively transformed into tumor cells that invade surrounding tissues and become malignant. Most prominent among the regulators disrupted in cancer cells are two tumor suppressors, the retinoblastoma protein (RB) and the p53 transcription factor. Here, we discuss interconnecting signaling pathways controlled by RB and p53, attempting to explain their potentially universal involvement in the etiology of cancer. Pinpointing the various ways by which the functions of RB and p53 are subverted in individual tumors should provide a rational basis for developing more refined tumor-specific therapies.

Integrity signals

Registry

Crossref · 10.1016/s1535-6108(02)00102-2

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Self-citation
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Self-citation
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“By inducing Arf and Ink4a in primary rodent fibroblasts, oncogenic Ras expression leads to growth arrest and premature senescence (Serrano et al., 1997; Ferbeyre et al., 2002).”
Background
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Untitled work
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585

Show all 122 references

Sorted by citations

Items 601–700 of 1,000

GRIM-19 and p16INK4a Synergistically Regulate Cell Cycle Progression and E2F1-responsive Gene Expression
Sun, P., Nallar, S. C., Raha, A., Kalakonda, S., Velalar, C. N., Reddy, S. P., & Kalvakolanu, D. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105767 · Cited by 37
Activation of NF-kB Pathway by Virus Infection Requires Rb Expression
García, M. Á., Gallego, P. P. F., Campagna, M., González, J., Martinez, G. M., Marcos-Villar, L., Vidal, A., Estéban, M., & Rivas, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006422 · Cited by 37
MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models
Fingerle‐Rowson, G., & Petrenko, O. (2007) · Cell Division · doi:10.1186/1747-1028-2-22 · Cited by 37
Dephosphorylation of Rb (Thr-821) in response to cell stress
Krucher, N. A., Rubin, E., Tedesco, V. C., Roberts, M. H., Sherry, T. C., & Leon, G. D. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.05.002 · Cited by 37
Role for PP2A in ARF signaling to p53
Moule, M. G., Collins, C. H., McCormick, F. P., & Fried, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405533101 · Cited by 37
Self-citation
Stevia rebaudiana Methanolic Leaf Extract in Egypt: Phytochemical Analysis, Antioxidant, Antilipid Peroxidation, Antihemolytic, Antimetastatic, and Anticancer Properties
Hanna, D. H., Osailan, R., & Ahmed, H. A. (2023) · Journal of Food Biochemistry · doi:10.1155/2023/7161091 · Cited by 36
The Sirtuin Inhibitor Tenovin-6 Upregulates Death Receptor 5 and Enhances Cytotoxic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells
Ueno, T., Endo, S., Saito, R., Hirose, M., Hirai, S., Suzuki, H., Yamato, K., & Hyodo, I. (2014) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504013x13854886566598 · Cited by 36
Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine
Höglund, A., Nilsson, L. M., Forshell, L. P., Maclean, K. H., & Nilsson, J. A. (2009) · Blood · doi:10.1182/blood-2008-10-183475 · Cited by 36
Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells
Connell, C. M., Shibata, A., Tookman, L. A., Archibald, K. M., Flak, M. B., Pirlo, K. J., Lockley, M., Wheatley, S. P., & McNeish, I. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43976 · Cited by 36
Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas.
Ragazzon, B., Libé, R., Assié, G., Tissier, F., Barreau, O., Houdayer, C., Perlemoine, K., Audebourg, A., Clauser, E., René-Corail, F., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0778 · Cited by 37
Detection of Promoter Hypermethylation of Tumor Suppressor Genes in Urine from Kidney Cancer Patients
Cairns, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.007 · Cited by 35
Adenovirus vector-mediated FAM176A overexpression induces cell death in human H1299 non-small cell lung cancer cells
Xie, H., Hu, J. N., Pan, H., Lou, Y., Lv, P., & Chen, Y. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.2.090 · Cited by 36
Finding minimum gene subsets with heuristic breadth-first search algorithm for robust tumor classification
Wang, S.-L., Li, X., & Fang, J. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-178 · Cited by 37
Genetically modified adenoviruses against gliomas
Gomez‐Manzano, C., Yung, W. K. A., Alemany, R., & Fueyo-Margareto, J. (2004) · Neurology · doi:10.1212/01.wnl.0000133302.15022.7f · Cited by 36
Mechanistic Insights of Thyroid Cancer Progression
Leandro-Garcia, L. J., & Landa, I. (2023) · Endocrinology · doi:10.1210/endocr/bqad118 · Cited by 37
Novel immunotherapeutic options for BCG‐unresponsive high‐risk non‐muscle‐invasive bladder cancer
Hannouneh, Z. A., Hijazi, A., Alsaleem, A. A., Hami, S., Kheyrbek, N., Tanous, F., Khaddour, K., Abbas, A., & Alshehabi, Z. (2023) · Cancer Medicine · doi:10.1002/cam4.6768 · Cited by 36
The Probable Cell of Origin of NF1- and PDGF-Driven Glioblastomas
Hambardzumyan, D., Cheng, Y.-K., Haeno, H., Holland, E. C., & Franziska Michor, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024454 · Cited by 36
Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas
Xie, C., Lu, H., Nomura, A., Hanse, E. A., Forster, C. L., Parker, J., Linden, M. A., Karasch, C., & Hallstrom, T. C. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0360-y · Cited by 35
TP53 and CDKN2a mutations in never‐smoker oral tongue squamous cell carcinoma
Heaton, C. M., Durr, M. L., Tetsu, O., van Zante, A., & Wang, S. J. (2014) · The Laryngoscope · doi:10.1002/lary.24595 · Cited by 35
Human rDNA and Cancer
Smirnov, E., Chmúrčiaková, N., & Cmarko, D. (2021) · Cells · doi:10.3390/cells10123452 · Cited by 37
Recent advances in understanding apoptosis: new therapeutic opportunities in cancer chemotherapy
Makin, G., & Dive, C. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00084-4 · Cited by 35
Retinoblastoma protein modulates gankyrin–MDM2 in regulation of p53 stability and chemosensitivity in cancer cells
Qiu, W., Wu, J., Walsh, E. M., Zhang, Y., Chen, C. Y., Fujita, J., & Xiao, Z.-X. J. (2008) · Oncogene · doi:10.1038/onc.2008.43 · Cited by 35
The CAR Nuclear Receptor and Hepatocyte Proliferation * #
Costa, R. H., Kalinchenko, V. V., Tan, Y., & Wang, I. (2005) · Hepatology · doi:10.1002/hep.20953 · Cited by 35
Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: Therapeutic targets
Motadi, L. R., Misso, N. L. A., Dlamini, Z., & Bhoola, K. D. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.07.013 · Cited by 35
RABL6A Promotes G1–S Phase Progression and Pancreatic Neuroendocrine Tumor Cell Proliferation in an Rb1-Dependent Manner
Hagen, J., Muniz, V. P., Falls, K. C., Reed, S. M., Taghiyev, A. F., Quelle, F. W., Gourronc, F. A., Klingelhutz, A. J., Major, H. J., Askeland, R. W., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3742 · Cited by 35
Cdk2 dethroned as master of S phase entry
Hinds, P. W. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00084-9 · Cited by 35
Retinoblastoma Tumor Suppressor: Analyses of Dynamic Behavior in Living Cells Reveal Multiple Modes of Regulation
Angus, S. P., Solomon, D. A., Kuschel, L., Hennigan, R. F., & Knudsen, E. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8172-8188.2003 · Cited by 35
RETRACTED ARTICLE: Distinct Action of the Retinoblastoma Pathway on the DNA Replication Machinery Defines Specific Roles for Cyclin-Dependent Kinase Complexes in Prereplication Complex Assembly and S-Phase Progression
Braden, W. A., Lenihan, J. M., Lan, Z., Luce, K. S., Zagórski, W., Bosco, E. E., Reed, M. F., Cook, J. G., & Knudsen, E. S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00045-06 · Cited by 36
Retracted
Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin
Liu, K., Lin, F., Graves, J. D., Lee, Y.-J., & Lin, W.-C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619832114 · Cited by 35
Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice
Martín‐Caballero, J., Flores, J. M., Garcı́a, P., Collado, M., & Serrano, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207863 · Cited by 35
E2F-1 overexpression increases viable cell density in batch cultures of Chinese hamster ovary cells
Majors, B. S., Arden, N., Oyler, G. A., Chiang, G. G., Pederson, N. E., & Betenbaugh, M. J. (2008) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2008.08.003 · Cited by 36
Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial
Pakola, S. A., Peltola, K. J., Clubb, J. H. A., Jirovec, E., Haybout, L., Kudling, T. V., Alanko, T., Korpisaari, R., Juteau, S., Jaakkola, M., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3874 · Cited by 34
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco‐Aparicio, C., Kondoh, H., LLeonart, M. E., Martínez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 36
MicroRNAs Regulate Key Effector Pathways of Senescence
Feliciano, A., Sánchez‐Sendra, B., Kondoh, H., & LLeonart, M. E. (2011) · Journal of Aging Research · doi:10.4061/2011/205378 · Cited by 34
The Role and Clinical Implications of the Retinoblastoma (RB)-E2F Pathway in Gastric Cancer
Wu, T., & Wu, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.655630 · Cited by 36
Targeting CDK7 in oncology: The avenue forward
Li, Z., Liu, G., Gao, Y., & Zhao, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108229 · Cited by 34
E2F1 suppresses Wnt/β-catenin activity through transactivation of β-catenin interacting protein ICAT
Wu, Z., Zheng, S., Li, Z., Tan, J. Y., & Yu, Q. (2011) · Oncogene · doi:10.1038/onc.2011.129 · Cited by 36
Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha- ras oncogene in rat pancreas
Ueda, S., Fukamachi, K., Matsuoka, Y., Takasuka, N., Takeshita, F., Naito, A., Iigo, M., Alexander, D. B., Moore, M. A., Saito, I., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl090 · Cited by 34
Cyclin-Dependent Kinase 6 Inhibits Proliferation of Human Mammary Epithelial Cells
Lucas, J. J., Domenico, J. M., & Gelfand, E. W. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.105.2.2 · Cited by 32
Telomerase activity and telomere on stem progeny senescence
Brazvan, B., Kalan, A. E., Velaei, K., Mehdipour, A., Serej, Z. A., Ebrahımı, A., Ghorbani, M., Cheraghi, O., & Charoudeh, H. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.073 · Cited by 36
Cell-Cycle Progression without an Intact Microtubule Cytoskeleton
Uetake, Y., & Sluder, G. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.065 · Cited by 34
DNA tumor viruses — the spies who lyse us
O’Shea, C. C. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.010 · Cited by 34
Negative regulation of nuclear divisions in Caenorhabditis elegans by retinoblastoma and RNA interference-related genes
Grishok, A., & Sharp, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508989102 · Cited by 34
RB and p53 Cooperate to Prevent Liver Tumorigenesis in Response to Tissue Damage
McClendon, A. K., Dean, J. L., Ertel, A., Fu, Z., Rivadeneira, D. B., Reed, C. A., Bourgo, R. J., Witkiewicz, A. K., Addya, S., Mayhew, C. N., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.046 · Cited by 33
Induction of Cancerous Stem Cells during Embryonic Stem Cell Differentiation
Fujimori, H., Shikanai, M., Teraoka, H., Masutani, M., & Yoshioka, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.372557 · Cited by 33
Inhibiting DX2-p14/ARF Interaction Exerts Antitumor Effects in Lung Cancer and Delays Tumor Progression
Oh, A.-Y., Jung, Y. S., Kim, J., Lee, J., Cho, J.-H., Chun, H.-Y., Park, S., Park, H., Lim, S. E. S., Ha, N., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1025 · Cited by 33
Targeted OMA1 therapies for cancer
Alavi, M. V. (2019) · International Journal of Cancer · doi:10.1002/ijc.32177 · Cited by 34
Altered Rb, p16, and p53 expression is specific for porocarcinoma relative to poroma
Zahn, J., Chan, M. P., Wang, G., Patel, R. M., Andea, A. A., Bresler, S. C., & Harms, P. W. (2019) · Journal of Cutaneous Pathology · doi:10.1111/cup.13480 · Cited by 33
An overview of lurbinectedin as a new second-line treatment option for small cell lung cancer
Patel, S. A., Petty, W. J., & Sands, J. M. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211020529 · Cited by 33
Patient-level proteomic network prediction by explainable artificial intelligence
Keyl, P., Bockmayr, M. L., Heim, D., Dernbach, G., Montavon, G., Müller, K., & Klauschen, F. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00278-4 · Cited by 34
microRNA-365-targeted nuclear factor I/B transcriptionally represses cyclin-dependent kinase 6 and 4 to inhibit the progression of cutaneous squamous cell carcinoma
Zhou, L., Wang, Y., Ou, C., Lin, Z., Wang, J., Liu, H., Zhou, M., & Ding, Z. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.06.009 · Cited by 33
Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1
Ugai, H., Dobbins, G. C., Wang, M., Le, L. P., Matthews, D. A., & Curiel, D. T. (2012) · Virology · doi:10.1016/j.virol.2012.05.028 · Cited by 32
Long Non-Coding RNAs Embedded in the Rb and p53 Pathways
Subramanian, M., Jones, M. F., & Lal, A. (2013) · Cancers · doi:10.3390/cancers5041655 · Cited by 33
Human TopBP1 Participates in Cyclin E/CDK2 Activation and Preinitiation Complex Assembly during G1/S Transition
Jeon, Y., Lee, K. Y., Ko, M. J., Lee, Y. S., Kang, S., & Hwang, D. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609116200 · Cited by 34
Inhibition of Infection and Replication of Human Herpesvirus 8 in Microvascular Endothelial Cells by Alpha Interferon and Phosphonoformic Acid
Krug, L. T., Pozharskaya, V. P., Yu, Y., Inoue, N., & Offermann, M. K. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8359-8371.2004 · Cited by 33
RBM38 Is a Direct Transcriptional Target of E2F1 that Limits E2F1-Induced Proliferation
Feldstein, O., Ben‐Hamo, R., Bashari, D., Efroni, S., & Ginsberg, D. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0331 · Cited by 34
A Retinoblastoma Allele That Is Mutated at Its Common E2F Interaction Site Inhibits Cell Proliferation in Gene-Targeted Mice
Cecchini, M. J., Thwaites, M. J., Talluri, S., MacDonald, J. I., Passos, D. T., Chong, J.-L., Cantalupo, P. G., Stafford, P. M., Sáenz-Robles, M. T., Francis, S. M., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01589-13 · Cited by 33
CDK phosphorylation of the discs large tumour suppressor controls its localisation and stability
Narayan, N., Massimi, P., & Banks, L. (2008) · Journal of Cell Science · doi:10.1242/jcs.024554 · Cited by 33
DNA-binding independent cell death from a minimal proapoptotic region of E2F-1
Bell, L. A., O’Prey, J., & Ryan, K. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209580 · Cited by 33
P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic Modulation
Papavassiliou, K. A., Sofianidi, A. A., Gogou, V. A., Anagnostopoulos, N., & Papavassiliou, A. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052479 · Cited by 33
Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation
Ferrer, I., Blanco‐Aparicio, C., Peregrina, S., Cañamero, M., Fominaya, J. M., Cecilia, Y., LLeonart, M. E., Hernández‐Losa, J., y Cajal, S. R., & Carnero, A. (2011) · Cell Cycle · doi:10.4161/cc.10.16.16422 · Cited by 31
5-Fluorouracil Mediates Apoptosis and G1/S Arrest in Laryngeal Squamous Cell Carcinoma via a p53-Independent Pathway
Liu, H. C., Chen, G. Y., Vlantis, A. C., Leung, B. C. S., Tong, M. C. F., & van Hasselt, C. A. (2006) · The Cancer Journal · doi:10.1097/00130404-200611000-00008 · Cited by 32
CDK2 Transcriptional Repression Is an Essential Effector in p53-Dependent Cellular Senescence—Implications for Therapeutic Intervention
Zalzali, H., Nasr, B., Harajly, M., Basma, H., Ghamloush, F., Ghayad, S. E., Ghanem, N., Evan, G. I., & Saab, R. H. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0163 · Cited by 32
Mitochondrial AIF loss causes metabolic reprogramming, caspase-independent cell death blockade, embryonic lethality, and perinatal hydrocephalus
Delavallée, L., Mathiah, N., Cabon, L., Mazeraud, A., Brunelle-Navas, M.-N., Lerner, L. K., Tannoury, M., Prola, A., Moreno‐Loshuertos, R., Baritaud, M., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101027 · Cited by 35
Meta‐analysis of expression of l(3)mbt tumor‐associated germline genes supports the model that a soma‐to‐germline transition is a hallmark of human cancers
Feichtinger, J., Larcombe, L. D., & McFarlane, R. J. (2013) · International Journal of Cancer · doi:10.1002/ijc.28577 · Cited by 32
Cell Cycle Regulated Gene Expression in Yeasts
McInerny, C. (2011) · Advances in genetics · doi:10.1016/b978-0-12-380860-8.00002-1 · Cited by 32
Zyflamend®-mediated inhibition of human prostate cancer PC3 cell proliferation: Effects on 12-LOX and Rb protein phosphorylation
Yang, P., Cartwright, C., Chan, D., Vijjeswarapu, M., Ding, J., & Newman, R. A. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.2.3624 · Cited by 32
GENETIC ABERRATIONS IN GLIOMATOSIS CEREBRI
Ware, M. L., Hirose, Y., Scheithauer, B. W., Yeh, R.-F., Mayo, M. C., Smith, J. S., Chang, S. M., Cha, S., Tihan, T., & Feuerstein, B. G. (2007) · Neurosurgery · doi:10.1227/01.neu.0000249203.73849.5d · Cited by 32
Differential Utilization of Cyclin D1 and Cyclin D3 in the Distinct Mitogenic Stimulations by Growth Factors and TSH of Human Thyrocytes in Primary Culture
Paternot, S., Dumont, J. E., & Roger, P. P. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0515 · Cited by 32
Targeting the AKT/cyclin D1 pathway to overcome intrinsic and acquired radioresistance of tumors for effective radiotherapy
Shimura, T. (2016) · International Journal of Radiation Biology · doi:10.1080/09553002.2016.1257832 · Cited by 32
The enigmatic role of cyclin D1 in multiple myeloma
Lesage, D., Troussard, X., & Sola, B. (2005) · International Journal of Cancer · doi:10.1002/ijc.20907 · Cited by 33
FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3α
Wierstra, I., & Alves, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.008 · Cited by 31
Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control
Ingemarsdotter, C. K., Tookman, L. A., Browne, A. K., Pirlo, K. J., Cutts, R. J., Chelela, C., Khurrum, K. F., Leung, E. Y. L., Dowson, S., Webber, L., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.007 · Cited by 31
Profiling of the metabolic transcriptome via single molecule molecular inversion probes
de Bitter, T. J. J., van de Water, C., van den Heuvel, C. N. A. M., Zeelen, C., Eijkelenboom, A., Tops, B. B. J., Oosterwijk, E., Kolev, D., Mulders, P., ter Laan, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11035-0 · Cited by 30
KISS1 tumor suppressor restricts angiogenesis of breast cancer brain metastases and sensitizes them to oncolytic virotherapy in vitro
Platonov, М. E., Borovjagin, A. V., Kaverina, N. V., Xiao, T., Григорьевна, К. З., Lesniak, M. S., Baryshnikova, M. A., & Ulasov, I. V. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.12.024 · Cited by 31
Expression of P16 and P53 in Non-Small-Cell Lung Cancer: Clinicopathological Correlation and Potential Prognostic Impact
Zhou, Y., Höti, N., Ao, M., Zhang, Z., Zhu, H., Li, L., Askin, F. B., Gabrielson, E., Zhang, H., & Li, Q. K. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0441 · Cited by 31
Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression
Xu, J., Huang, F., Yao, Z., Jia, C., Xiong, Z., Liang, H., Lin, N., & Deng, M. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0398-3 · Cited by 31
Clinical Role of Epigenetics and Network Analysis in Eye Diseases: A Translational Science Review
Lanza, M., Benincasa, G., Costa, D., & Claudio Napoli, A. (2019) · Journal of Ophthalmology · doi:10.1155/2019/2424956 · Cited by 32
The molecular mechanisms of virus-induced human cancers
Ameya, G., & Birri, D. J. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106292 · Cited by 31
Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner
Haupt, S., Mitchell, C., Corneille, V., Shortt, J., Fox, S. B., Pandolfi, P. P., Castillo-Martín, M., Bonal, D. M., Cordon-Carlo, C., Lozano, G., et al. (2013) · Cell Cycle · doi:10.4161/cc.24805 · Cited by 29
Rb/E2F1 Regulates the Innate Immune Receptor Toll-Like Receptor 3 in Epithelial Cells
Taura, M., Suico, M. A., Koyama, K., Komatsu, K., Miyakita, R., Matsumoto, C., Kudo, E., Kariya, R., Goto, H., Kitajima, S., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06454-11 · Cited by 30
Tumor promotion by caspase-resistant retinoblastoma protein
Borges, H. L., Bird, J., Wasson, K., Cardiff, R. D., Varki, N. M., Eckmann, L., & Wang, J. Y. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503925102 · Cited by 31
Control of Eukaryotic DNA Replication Initiation—Mechanisms to Ensure Smooth Transitions
Reußwig, K.-U., & Pfander, B. (2019) · Genes · doi:10.3390/genes10020099 · Cited by 31
p14ARF Protein Expression Is a Predictor of Both Relapse and Survival in Squamous Cell Carcinoma of the Anterior Tongue
Kwong, R. A., Kalish, L. H., Nguyen, T. V., Kench, J. G., Bova, R., Cole, I. E., Musgrove, E. A., & Sutherland, R. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2036 · Cited by 31
Cigarette Smoking and p16INK4α Gene Promoter Hypermethylation in Non-Small Cell Lung Carcinoma Patients: A Meta-Analysis
Zhang, B., Zhu, W., Yang, P., Liu, T., Jiang, M. H., He, Z., Zhang, S., Chen, W., & Chen, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028882 · Cited by 30
Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets
Halldén, G., & Portella, G. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.712962 · Cited by 30
Nuclear Nox4 interaction with prelamin A is associated with nuclear redox control of stem cell aging
Casciaro, F., Beretti, F., Zavatti, M., McCubrey, J. A., Ratti, S., Marmiroli, S., Follo, M. Y., & Maraldi, T. (2018) · Aging · doi:10.18632/aging.101599 · Cited by 30
Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer
Malfitano, A. M., Somma, S. D., Prevete, N., & Portella, G. (2019) · Cancers · doi:10.3390/cancers11101532 · Cited by 30
MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6
Wang, X., Chang, K., Gao, J., Wei, J., Xu, G., Xiao, L., & Song, G. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105663 · Cited by 30
Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma
Rao, R. S., Lizbeth Raju, K., Augustine, D., & Patil, S. (2020) · Cancer Control · doi:10.1177/1073274820904959 · Cited by 30
Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications
van Harten, A. M., & Brakenhoff, R. H. (2021) · Cancers · doi:10.3390/cancers13112774 · Cited by 33
An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia
Geron, I., Savino, A. M., Fishman, H., Tal, N., Brown, J., Turati, V. A., James, C. T., Sarno, J., Hameiri-Grossman, M., Lee, Y. N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28218-7 · Cited by 33
Modulation of the ARF-p53 Pathway by the Small DNA Tumor Viruses
O’Shea, C. C., & Fried, M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1555 · Cited by 29
Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart
Verbeke, S., Bertoni, F., Bacchini, P., Oosting, J., Sciot, R., Krenács, T., & Bovée, J. V. M. G. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.56 · Cited by 30
Preventive Effects of Bexarotene and Budesonide in a Genetically Engineered Mouse Model of Small Cell Lung Cancer
Wang, Y., Wen, W., Yi, Y., Zhang, Z., Lubet, R. A., & You, M. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0221 · Cited by 30
The G1 phase Cdks regulate the centrosome cycle and mediate oncogene-dependent centrosome amplification
Harrison, M. K., Adon, A. M., & Saavedra, H. I. (2011) · Cell Division · doi:10.1186/1747-1028-6-2 · Cited by 32
Dissecting the Senescence-like Program in Tumor Cells Activated by Ras Signaling
Bihani, T., Chicas, A., Lo, C. P.-K., & Lin, A. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608127200 · Cited by 30
E2F3—A Novel Repressor of the ARF/p53 Pathway
Ginsberg, D. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.05.012 · Cited by 30
A Novel Assay to Assess Primary Human Cancer Infectibility by Replication-Selective Oncolytic Adenoviruses
Wang, Y., Thorne, S. H., Hannock, J., Francis, J., Au, T., Reid, T. R., Lemoine, N., Kirn, D. H., & Halldén, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.351.11.1 · Cited by 30
Effects of Auraptene on IGF-1 Stimulated Cell Cycle Progression in the Human Breast Cancer Cell Line, MCF-7
Krishnan, P., & Kleiner‐Hancock, H. E. (2012) · International Journal of Breast Cancer · doi:10.1155/2012/502092 · Cited by 30

Authors: Sherr, C. J., & McCormick, F.
Affiliations: St. Jude Children's Research Hospital (US)
University of California, San Francisco (US)
Corresponding author: Sherr, Charles J
ORCID: Sherr, Charles J
McCormick, Frank
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2002-08
Volume: 2
Issue: 2
Pages: 103-112
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/s1535-6108(02)00102-2
OpenAlex: W1992708996
Cited by: 1,690
References: 122
Citations by year: 2026: 31 · 2025: 40 · 2024: 36 · 2023: 60 · 2022: 56 · 2021: 62 · 2020: 62 · 2019: 67 · 2018: 75 · 2017: 67 · 2016: 60 · 2015: 71 · 2014: 88 · 2013: 81 · 2012: 90
FWCI: 7.67
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4003 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: retinoblastoma protein, p53, tumor suppressor, malignant transformation, signaling pathways, cancer etiology, tumor-specific therapy, oncogenic transformation
MeSH terms: Cell Cycle, DNA-Binding Proteins, Humans, Neoplasms, Transcription Factors, Signal Transduction, Tumor Suppressor Protein p53, Retinoblastoma Protein, Apoptosis, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, E2F Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The RB and p53 pathways in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks